Curaleaf Q3 2026 net loss narrows 42% year over year to USD 32.72 million

• Curaleaf’s third-quarter 2026 net loss attributable to shareholders narrowed 43% year-over-year to USD 32.72 million.
• Net revenue rose 11% year-over-year to USD 352.65 million.
• Following the quarter, it raised its Aurora acquisition offer and is evaluating options following Aurora’s announcement of an alternative merger with Organigram.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Curaleaf Holdings Inc. published the original content used to generate this news brief via CNW (Ref. ID: 202611031601CANADANWCANADAPR_C1067) on November 03, 2026, and is solely responsible for the information contained therein.